Aberrant promoter methylation profile associated with survival in patients with non-small cell lung cancer

被引：0
|
作者：
Gu, Jian [1 ]
Spitz, Margaret R. [1 ]
Roth, Jack A. [1 ]
Wu, Xifeng [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
28
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Polymorphisms in MicroRNAs Are Associated with Survival in Non-Small Cell Lung Cancer
    Zhao, Yang
    Wei, Qingyi
    Hu, Lingming
    Chen, Feng
    Hu, Zhibin
    Heist, Rebecca S.
    Su, Li
    Amos, Christopher I.
    Shen, Hongbing
    Christiani, David C.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11) : 2503 - 2511
  • [32] Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients
    Wang, Xi-en
    Wang, You-hui
    Zhou, Qiang
    Peng, Min
    Zhang, Jing
    Chen, Mi
    Ma, Li-juan
    Xie, Guo-ming
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 499 - 505
  • [33] The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer
    Chen, JT
    Cheng, YW
    Chou, MC
    Sen-Lin, T
    Lai, WW
    Ho, WL
    Lee, H
    CLINICAL CANCER RESEARCH, 2003, 9 (11) : 4200 - 4204
  • [34] Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer
    Shicheng Guo
    Lixing Tan
    Weilin Pu
    Junjie Wu
    Kuan Xu
    Jinhui Wu
    Qiang Li
    Yanyun Ma
    Jibin Xu
    Li Jin
    Jiucun Wang
    Clinical Epigenetics, 2014, 6
  • [35] RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer
    Dutkowska, A.
    Antczak, A.
    Pastuszak-Lewandoska, D.
    Migdalska-Sek, M.
    Czarnecka, K. H.
    Gorski, P.
    Kordiak, J.
    Nawrot, E.
    Brzezianska-Lasota, E.
    ADVANCES IN CLINICAL SCIENCE, 2016, 878 : 29 - 38
  • [36] Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation
    Soria, JC
    Lee, HY
    Lee, JI
    Wang, L
    Issa, JP
    Kemp, BL
    Liu, DD
    Kurie, JM
    Mao, L
    Khuri, FR
    CLINICAL CANCER RESEARCH, 2002, 8 (05) : 1178 - 1184
  • [37] Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer
    Geng, Xin
    Pu, Weilin
    Tan, Yulong
    Lu, Zhouyi
    Wang, An
    Tan, Lixing
    Chen, Sidi
    Guo, Shicheng
    Wang, Jiucun
    Chen, Xiaofeng
    ONCOTARGET, 2017, 8 (04) : 6845 - 6856
  • [38] Dose effect of smoking on aberrant methylation in non-small cell lung cancers
    Toyooka, S
    Suzuki, M
    Tsuda, T
    Toyooka, KO
    Maruyama, R
    Tsukuda, K
    Fukuyama, Y
    Iizasa, T
    Fujisawa, T
    Shimizu, N
    Minna, JD
    Gazdar, AF
    INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (03) : 462 - 464
  • [39] Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer
    Guo, Shicheng
    Tan, Lixing
    Pu, Weilin
    Wu, Junjie
    Xu, Kuan
    Wu, Jinhui
    Li, Qiang
    Ma, Yanyun
    Xu, Jibin
    Jin, Li
    Wang, Jiucun
    CLINICAL EPIGENETICS, 2014, 6
  • [40] Correlation between DAPK Promoter Methylation and Gefitinib Sensitivity in Non-small Cell Lung Cancer
    Wu Weiqin
    Zhang Xiaoyuan
    Xu Haifeng
    Xu Jing
    Shen Jie
    Lu Kaihua
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 152 - 157
12345